Health care stocks advanced late Friday afternoon with the NYSE Health Care Index and the Health Care Select Sector SPDR Fund (XLV) both adding 0.9%.
The iShares Biotechnology ETF (IBB) also climbed 0.9%.
In corporate news, IceCure Medical (ICCM) shares rose 4.9% after the company received an intention to grant notice from the European Patent Office for its cryoablation technology.
Bionano Genomics (BNGO) shares jumped 20%. The company announced a registered direct offering to certain institutional investors for almost 39.7 million shares and related warrants at $0.252 apiece to raise $10 million.
Cyclacel Pharmaceuticals (CYCC) shares surged 26% after investor David Lazar agreed to buy $3.1 million in the company's preferred stock and was named interim chief executive.
Neumora Therapeutics' (NMRA) readout of its first phase 3 trial of navacaprant in major depressive disorder was a "significant miss," though the company has two more chances, Mizuho Securities said in a report. Neumora shares rose 13%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.